ARCHIVES

LabCorp Marketing Of Ovarian Cancer Test Unlawful, FDA Says In Warning Letter.

This article is from The Cancer Letter archive.

Vol. 34 No. 38 | October 17, 2008

Download PDF Visit The Full Archive

Related Articles

First analysis From Profiles Reveal New Data On Centers

November 18, 1977

SWOG Closes Prostate Cancer Trial With Mitoxantrone

February 23, 2007

ODAC Votes for Marqibo Accelerated Approval

March 30, 2012

ASCO Advises KRAS Testing In Patients With Metastatic Colorectal Cancer

January 30, 2009

Trials Suspended At Oklahoma Over Study Of Cancer Vaccine.

July 14, 2000

Test May Identify Predictors For Recurrence Post-Surgery

January 28, 2011